 FARMINGDALE, N.Y., March 04, 2021 GLOBE NEWSWIRE -- Misonix, Inc. NASDAQ: MSON Misonix or the Company, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus Ultrasonic Surgical System. This approval confirms that neXus meets the requirements of Health Canada, allowing Misonix to commercialize neXus, along with its various handpieces and disposable products, across Canada. 